EpiWatch occupies a distinctive niche as an Apple Watch-native seizure detection app, leveraging consumer hardware to provide passive monitoring without requiring dedicated medical wearables. Its FDA clearance and Johns Hopkins collaboration lend credibility, though tonic-clonic seizure detection sensitivity on wrist accelerometry is lower than EEG-based systems, limiting its use to a specific patient population.